This symposium is intended for urologists and other members of the surgical team who perform renal and prostate robotic surgery. The geographical region of the Pacific Northwest, comprising of WA, OR, ID, MT and AK, are provided for by this symposium.
New robotically assisted surgery methods and devices are helping to push the boundaries of medicine. By focusing on fewer incisions, more precision and more versatility with these procedures and devices, surgery is becoming safer and more efficient.
Today, robotics touches every surgical specialty, and within each specialty, it runs the gamut of procedural applications. Robotic surgery has exponentially increased in urologic oncology, specifically for radical prostatectomy and partial nephrectomy. In less than a decade, the widespread application of robotic technology to the field of urologic oncology has permanently altered the way urologists approach malignancy.
This symposium will outline improvements in surgical techniques in robotic prostatectomy and robotic partial nephrectomy. Robotic surgeons will learn tips and technical details to implement new robotic techniques in their practice. In addition, examples of the advancements in robotic surgery will be demonstrated using real-time live surgery and video presentations.
Directors & Faculty
James Porter, MD
Dr. James Porter is the most experienced minimally invasive, laparoscopic, robotic surgeon in the Pacific Northwest. He received his laparoscopic training in Heilbron, Germany, and returned to be the first surgeon in the Northwest to use the laparoscopic approach for radical and donor nephrectomy, partial nephrectomy, retroperitoneal lymph node dissection, and radical prostatectomy. Dr. Porter has been active in teaching and promotion of laparoscopic minimally invasive surgical techniques to the regional and national urologic community. Dr. Porter also performs cutting-edge surgery using the da Vinci® surgical system, such as the prostatectomies, partial nephrectomies and other urologic procedures. Dr. Porter is currently the Medical Director for Robotic Surgery at Swedish Medical Center where he also directs the Robotic and Laparoscopic Fellowship in Urology.
6:30 am - 7:00 am
Registration and Continental Breakfast
7:00 am - 7:10 am
Welcome and Introduction of Course Objectives
7:10 am - 7:25 am
Retroperitoneal Partial Nephrectomy
7:25 am - 7:40 am
Patient Positioning, Port Placement and Docking
7:40 am - 7:55 am
The Steps: Hilar Control to Renorrhaphy
7:55 am - 8:00 am
Live Surgery-Case Presentation and Patient Set Up
8:00 am - 9:45 am
Live Surgery: Retroperitoneal Robotic Partial Nephrectomy
10:15 am - 10:35 am
Robotic Simple Prostatectomy for BPH
10:35 am - 10:55 am
Patient Safety and Quality Measures of Surgery
10:55 am - 11:15 am
Renal Mass Biopsy, Active Surveillance and Follow Up Strategies
11:15 am - 11:30 am
Reducing Warm Ischemia Time During Robotic Partial Nephrectomy
11:30 am - 11:50 am
Robotic Prostatectomy for High Risk Prostate Cancer and Extended Pelvic Lymph Node Dissection
11:50 am - 12:00 pm
Question and Answers
1:00 pm - 1:10 pm
Live Surgery-Case Presentation and Patient Set Up
1:10 pm - 2:30 pm
Live Surgery: Robotic Prostatectomy with Extended Pelvic Lymph Node Dissection
2:30 pm - 3:00 pm
Anatomic Robotic Prostatectomy - How I Do It
3:30 pm - 3:45 pm
Robotic Partial Nephrectomy for Complex Tumors
3:45 pm - 4:15 pm
Challenging Case Presentations
4:15 pm - 5:00 pm
Robotic Complications: Case Presentation and Management
5:00 pm - 5:15 pm
Questions and Adjourn
- Robotic Partial Nephrectomy
- Hilar Control to Renorrhaphy
- Fluorescence Imaging During Robotic Nephrectomy
- Pre and Post Op Care
- Clinical Pathways
- Retroperitoneal Partial Nephrectomy
- Robotic Nephroureterectomy and Pyeloplasty
- Robotic RPLND for Testis Cancer
At the conclusion of this symposium, the participant will provide better patient care through an increased ability to:
- Describe the indications for robotic partial nephrectomy (RPN), robotic prostatectomy (RP), and for pelvic lymph node dissection.
- Identify patients who are appropriate candidates for RPN, explain operating room set-up, describe proper patient positioning and potential positioning complications and recognize the variations in port placement.
- Perform proper hilar dissection and hilar control and describe the steps for robot-assisted renorrhaphy during RPN.
- Optimally manage patients, demonstrate proper port position for transperitoneal approach and apply strategies and techniques used by the experts.
- Describe the role of robotics in the treatment of advanced renal cell carcinoma, identify ideal candidates for surgical debulking procedures and describe potential complications of robotic surgery in patients with advanced renal cell carcinoma.
- Describe the technique of fluorescence imaging during RPN, recognize appropriate candidates for fluorescence imaging and identify limitations of fluorescence imaging.
- Explain the pre-operative preparations and the post-operative care for patients undergoing RPN and identify potential issues that may preclude RPN.
- Identify patients for retroperitoneal RPN, describe and discuss landmarks for safe retroperitoneal surgery and review contraindications for retroperitoneal RPN .
- Describe implementation of a patient care pathway for robotic renal and robotic prostatectomy. Identify the advantages of a care pathway over conventional post operative patient care.
- Identify indications for robotic retroperitoneal lymph node dissection (RPLND), describe the technique for robotic RPLND and review port placement for unilateral and bilateral RPLND.
- Review and discuss the evolving role of robotic surgery for the treatment of prostate cancer, describe the indications for robotic prostatectomy (RP) and identify patients who are appropriate candidates for RP based on patient characteristics and prostate size.
- Identify indications for simple prostatectomy, describe the technical aspects of simple prostatectomy and evaluate the differences between simple and radical prostatectomy.
- Describe current prostate cancer risk stratification, assess the limitations of the Prostate-Specific Antigen (PSA) test as a risk stratification tool and discuss molecular staging strategies.
- Recognize indications for extended pelvic lymph node dissection during robotic laparoscopic prostatectomy, describe port placement and technique of extended pelvic lymph node dissection (PLND) and discuss therapeutic benefit of extended PLND
- Define continence after prostatectomy, discuss the impact of technique vs. patient characteristics on continence and describe the technical modifications to improve continence.
- Describe patient characteristics that impact potency after RP, review optimal techniques for nerve-sparing prostatectomy and describe post-operative rehabilitation strategies to optimize potency.
- Review and discuss measures to prevent complications during RP, identify strategies and techniques used by the experts in dealing with unexpected complications and review and discuss the role of the surgical team during complicated procedures.